Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 10—October 2002
THEME ISSUE
Bioterrorism-related Anthrax
Bioterrorism-related Anthrax

Adherence to Antimicrobial Inhalational Anthrax Prophylaxis among Postal Workers, Washington, D.C., 2001

Mariaelena D. Jefferds*Comments to Author , Kayla F. Laserson*, Alicia M. Fry*, Sharon L. Roy*, James Hayslett*, Laurence Grummer-Strawn*, Laura Kettel-Khan*, Anne Schuchat*, and selected members of the Centers for Disease Control and Prevention Anthrax Adherence Team1
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA;

Main Article

Table 2

Characteristics of postal workers with intermediate and full adherence to prophylaxis for inhalational anthrax, Washington, D.C., 2001a

Characteristics Intermediate (n=102)
n (%) Full (n=98)
n (%) RR (95% CI) p value
Sexb
Female 43 (42) 52 (54) 0.8 (0.6, 1.05) n.s
Male 59 (58) 45 (46) Ref -
Age,b (y)
18–44 34 (33) 16 (16) 2.0 (1.2, 3.4) p<0.05
>45 68 (67) 81 (84) Ref -
Race/ethnicityb
Black 90 (88) 88 (91) 1.0 (0.9, 1.1) n.s.
Other 5 (5) 3 (3) 1.6 (0.4, 6.5) n.s.
White 7 (7) 6 (6) Ref -
Work description at interviewc
Driver 12 (12) 8 (8) 1.4 (0.6, 3.3) n.s.
Government mail 17 (16) 21 (21) 0.8 (0.4, 1.4) n.s.
Administration 7 (7) 6 (6) 1.1 (0.4, 3.2) n.s.
Plant floor 66 (65) 63 (64) Ref -
Worked on sorter or in government mail sectiond
Yes 70 (72) 70 (75) 0.9 (0.8, 1.1) n.s.
No 27 (28) 23 (25) Ref -
Perceived riske
High 58 (57) 60 (61) 0.9 (0.7, 1.2) n.s.
Some 39 (38) 35 (36) 1.1 (0.7, 1.5) n.s.
None 5 (5) 3 (3) Ref -
Adverse effectsf
A lot 20 (20) 9 (9) 2.1 (1.02, 4.4) p<0.05
Some 54 (53) 48 (49) 1.1 (0.8, 1.4) n.s.
Not at all 28 (27) 41 (42) Ref -
Physical signs of stressg
5–11 signs 37 (36) 28 (29) 1.3 (0.8, 1.9) n.s.
1–4 signs 50 (49) 57 (58) 0.8 (0.6, 1.1) n.s.
0 signs 15 (15) 13 (13) Ref -
Anxietyh
Yes 37 (36) 33 (34) 1.1 (0.7, 1.6) n.s.
No 65 (64) 65 (66) Ref -
Trouble remembering pillsi
Yes 67 (66) 44 (45) 1.5 (1.1, 1.9) p<0.05
No 35 (34) 54 (55) Ref -
Worse work performancej
Yes 16 (16) 15 (15) 1.0 (0.5, 1.9) n.s.
No 86 (84) 83 (85) Ref -

aRR, relative risk; 95% CI, 95% confidence interval; n.s., not statistically significant; ref, referent.
bOne missing value for full adherence.
cWork location during the survey interview, December 18–20, 2001.
dWorked close to these areas for more than half of the normal workdays during exposure period of October 12–21, 2001. Responses of “don’t know” were excluded from analysis (n=13).
ePerceived risk of breathing in Bacillus anthracis spores during exposure period of October 12–21, 2001.
fReported how much side effects affected their lives.
gPhysical signs of stress included fatigue, headaches, chest pain, rapid heartbeat, unplanned changes in weight, less sleep or difficulty sleeping, muscle tremors or twitches, difficulty or rapidity in breathing, elevated blood pressure, nausea or vomiting, and dizziness or lightheadedness.
hReported they experienced anxiety since anthrax events started. Anxiety was one of 22 listed physical, emotional, mental, and behavioral signs of stress on our questionnaire.
iReported they sometimes or almost always had trouble remembering their pills.
jReported side effects negatively affected their work performance.

Main Article

1 The following members of the team were involved in the Washington, D.C., area response: Theodies Mitchell, Charlie Chamberlain, Arlene Shaw, Margaret Patterson, Chang Lee, Daryle Hardge, Veronica McCant, Robert Fireall, Colleen Crowley, Sandra Mattson, Margaret Tipple, Suzanne Lebovit, Pat Cook, Valerie J. Curry, Kelly Holton, Susan L. Lukacs, Julia C. Rhodes, Cindy R. Friedman, Holly A. Williams, Michelle G. Goveia, Leigh Winston, Heather Burke, Veronica Alvarez, Gail M. Stennies, Ernest E. Smith, Brigette Finkelstein, Julia Smith, Bobbie Person, Ian Williams, Wanda Walton, Nick Deluca, Regina Bess, Gabrielle Benenson, Kathleen Hutchins, and Luetta Schneider.

Page created: July 19, 2010
Page updated: July 19, 2010
Page reviewed: July 19, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external